Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6848394 | 0.91 | ALDH1A1 (0.46) | ALDH1A1TP53TSHR | |
| SCHEMBL7747368 | 0.85 | — | — | |
| SCHEMBL5320548 | 0.78 | LMNA (0.48) | ALDH1A1TP53TSHR | |
| Hydrochloric Acid SCHEMBL6339249 | 0.76 | LMNA (0.46) | ALDH1A1TP53TSHR | |
| SCHEMBL28393723 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TP53TSHR | |
| SCHEMBL163601 | 0.72 | — | — | |
| SCHEMBL6848304 | 0.71 | TSHR (0.56) | ALDH1A1TSHR | |
| SCHEMBL591834 | 0.70 | — | — | |
| SCHEMBL6821345 | 0.70 | MAPT (0.56) | TSHR | |
| SCHEMBL6821586 | 0.70 | FAAH (0.50) | ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6852888-B2 | Carboxylic acid derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2005-02-08 | — | — | US | disclosed |
| EP-1084100-B1 | DIFLUOROALKENCARBOXANILIDES AND PESTICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2004-07-14 | — | — | EP | disclosed |
| EP-0661289-B1 | Vinyl carboxamide derivatives as insecticides and acaricides | SYNGENTA PARTICIPATIONS AG (CH) | 2004-03-03 | — | — | EP | disclosed |
| US-20030216467-A1 | Carboxylic acid derivatives | SYNGENTA CROP PROTECTION, INC. (FORMERLY KNOWN AS NOVARTIS CROP PROTECTION, INC.) | 2003-11-20 | — | — | US | disclosed |
| EP-1084100-A1 | DIFLUOROALKENCARBOXANILIDES AND PESTICIDAL COMPOSITIONS | Novartis AG (CH) | 2001-03-21 | — | — | EP | disclosed |
| EP-0986534-A2 | ORGANIC COMPOUNDS | Novartis AG (CH) | 2000-03-22 | — | — | EP | disclosed |
| WO-1999062866-A1 | DIFLUOROALKENCARBOXANILIDES AND PESTICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 1999-12-09 | — | — | WO | disclosed |
| WO-1998055448-A2 | FLUOROALKENE CARBOXYLIC ACID DERIVATIVES, METHOD FOR PRODUCING SAID DERIVATIVES, AND INSECTICIDAL AGENTS CONTAINING THE SAME | NOVARTIS AG (CH) | 1998-12-10 | — | — | WO | disclosed |
| US-5763481-A | PESTICIDES; INSECTICIDES, MITICIDES | NOVARTIS CORPROATION (US) | 1998-06-09 | — | — | US | disclosed |
| US-5545630-A | PESTICIDES | CIBA-GEIGY CORPORATION (US) | 1996-08-13 | — | — | US | disclosed |
| EP-0661289-A1 | Vinyl carboxamide derivatives as insecticides and acaricides | CIBA-GEIGY AG (CH) | 1995-07-05 | — | — | EP | disclosed |
| US-5248810-A | Insecticides, acaricides | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-09-28 | — | — | US | disclosed |
| EP-0432861-A1 | Halogenated olefines, process for the preparation thereof and their use as pesticides | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216467-A1 | Carboxylic acid derivatives | CLIC1, CNPY3, HCFC1 | ALDH1A1 1211/4885TP53 4518/4885TSHR 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.